53622-33-6Relevant academic research and scientific papers
Copper(0)/Selectfluor System-Promoted Oxidative Carbon-Carbon Bond Cleavage/Annulation of o-Aryl Chalcones: An Unexpected Synthesis of 9,10-Phenanthraquinone Derivatives
Bao, Hanyang,Xu, Zheng,Wu, Degui,Zhang, Haifeng,Jin, Hongwei,Liu, Yunkui
, p. 109 - 118 (2017)
A general and efficient protocol for the synthesis of 9,10-phenanthraquinone derivatives has been successfully developed involving a copper(0)/Selectfluor system-promoted oxidative carbon-carbon bond cleavage/annulation of o-aryl chalcones. A variety of substituted 9,10-phenanthraquinones were synthesized in moderate to good yields under mild reaction conditions.
Synthesis method of 9,10-phenanthrenequinone compound
-
Paragraph 0062-0067; 0092, (2018/04/02)
The invention provides a preparation method of a 9,10-phenanthrenequinone compound. The preparation method comprises: reacting a raw material, namely 2-aryl cinnamaldehyde as shown in the formula I inan organic solvent at the temperature of 0-50 DEG C for 12-36h under the actions of a copper catalyst and an oxidant, and separating and purifying the obtained reaction liquid to prepare the 9,10-phenanthrenequinone compound as shown in the formula II. The preparation method is simple and available in raw material, mild in reaction condition, capable of avoiding using an expensive and poisonouscatalyst or ligand, safe and environment-friendly, high in atom economy and simple in operation, and a novel method is provided for synthesizing 9,10-phenanthrenequinone containing various substituentgroups.
Compositions with triarylamine derivatives and oled device containing the same
-
Paragraph 0198; 0199; 0200, (2017/10/05)
The present disclosure provides a composition. In an embodiment, a composition is provided and comprises a Compound 1 shown below: For Compound 1, R1 through R24 are the same or different. R1 through R24 each is independently selected from the group consisting of hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, cyano, alkoxy, aryloxy, and NR'2. R' is hydrogen or hydrocarbyl; wherein two or more of adjacent R1 to R24 may optionally form one or more ring structures. The Component Z is selected from the group consisting Group Z-1, Group Z-2, Group Z-3, Group Z-4, Group Z-5, Group Z-6 and Group Z-7 shown below: For Compound 1, one or more hydrogen atoms may optionally be substituted with deuterium.
Cd45 inhibitors
-
, (2008/06/13)
Substituted phenanthrene-9,10-diones in accord with structural diagram I, 1compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection. In compounds of the invention, R1 at each occurrence is independently selected from hydrogen, halogen, NH-tosyl, N-di-tosyl, NH2, NO2, NH—CO—R2, CO—NH—R2, Ar, (CH2)nCH(COOH)R3 COR3 and NHCOCH2CH(COOH)NHR4, where R2, R3 and R4 are a selected from a variety of substituted or unsubstituted alkyl and aryl groupstand oligopeptides.

